Introduction to Role
At AstraZeneca, we turn ideas into life-changing medicines. Working here means being entrepreneurial, thinking big, and collaborating to make the impossible a reality. We are passionate about the potential of science to address the unmet needs of patients around the world and focus on areas where we believe we can meaningfully change the course of disease.
As the US Medical Franchise Head, Hematology , you will provide strategic and scientific leadership for the US Hematology Medical Affairs organization. You will be accountable for defining and delivering the US Medical strategy across the hematology franchise, translating emerging science and insights from the healthcare ecosystem into strategies that advance patient care and enhance the impact of our portfolio.
You will lead a high-performing organization spanning headquarters and field medical teams, partner closely with Global Medical, R&D, Commercial, Market Access, Real-World Evidence, Government Affairs, and Patient Advocacy, and serve as a senior medical voice for the hematology franchise in the US.
Accountabilities
Set and lead the US Medical strategy for the Hematology franchise , ensuring alignment with US business priorities, Global Medical strategy, lifecycle plans, and evolving patient, provider, payer, and healthcare system needs.
Deliver a coordinated US medical evidence generation strategy across the hematology portfolio, including late-phase and post-approval studies, real-world evidence, health outcomes research, externally sponsored research, and other evidence-generation activities developed to address clinically relevant evidence gaps.
Lead the US Hematology Medical Affairs organization , including headquarters and field medical teams, crafting an environment characterized by scientific excellence, innovation, accountability, inclusion, collaboration, and high performance.
Provide strategic oversight and leadership across the hematology portfolio , ensuring Medical strategies and plans support assets across different stages of the product lifecycle, from launch readiness and indications under development through lifecycle management and mature brands.
Build organizational capability and a strong talent pipeline by establishing clear accountabilities, developing and retaining outstanding talent, strengthening succession plans, and encouraging continuous learning and improvement.
Generate and translate actionable medical insights from healthcare professionals, scientific leaders, patients, payers, treatment centers, and other partners to advise US and Global Medical strategy, evidence-generation priorities, clinical development, and portfolio decisions.
Lead strategic engagement with external scientific and medical leaders , including hematologists, oncologists, investigators, academic institutions, collaborative groups, medical societies, and other organizations crafting the future of hematology care.
Advance the scientific exchange strategy for the franchise , ensuring field medical teams are equipped to engage credibly and stays in sync with external partners regarding evolving science, treatment paradigms, unmet needs, and the AstraZeneca hematology portfolio.
Partner across functions and geographies , including R&D, Global Medical Affairs, Commercial, Market Access, Real-World Evidence, HEOR, Regulatory, Government Affairs, Corporate Affairs, and Patient Advocacy, to ensure a coordinated approach to advancing patient outcomes.
Serve as a senior US Medical representative for Hematology in key governance forums, providing scientific and medical leadership to portfolio, investment, lifecycle, launch, and business development decisions.
Identify emerging trends and innovations in hematology , including new therapeutic modalities, diagnostics, biomarkers, treatment pathways, and models of care, and translate these developments into implications for AstraZeneca's portfolio and Medical strategy.
Champion compliant, ethical, and…